Predicting Disease Progression in Inoperable Localized NSCLC Patients Using ctDNA Machine Learning Model.

As shown in Table 1 , the combined method showed higher overall accuracies at three time points (TP1, TP2 and TP3) with trend toward significance than both the neomer model ( t ‐test, p = 0.0931) and the ctDNA mutation‐based method ( t ‐test, p = 0.0564).

also in 304 other papers